CD123 bi-specific antibodies in development in AML: What do we know so far?

Michael J. Slade, Geoffrey L. Uy

Research output: Contribution to journal › Review article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'CD123 bi-specific antibodies in development in AML: What do we know so far?'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology